The short version
17 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Lacosamide
Lacosamide · LACOSAMIDE 10 mg/mL · Injection · Intravenous · Gland Pharma Limited
NDC 68083-0480-10 · 10 VIAL, SINGLE-DOSE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $188.78 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA215628
- TE code
- AP
- Approval date
- Sep 19, 2022
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Lacosamide (Injection)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Zydus Pharmaceuticals USA Inc. | LACOSAMIDE 10 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Apotex Corp | LACOSAMIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Camber Pharmaceuticals, Inc. | LACOSAMIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories Inc. | LACOSAMIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Fosun Pharma USA | LACOSAMIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | LACOSAMIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Gland Pharma Limited | LACOSAMIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Indoco Remedies Limited | LACOSAMIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| NorthStar RxLLC | LACOSAMIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Novadoz Pharmaceuticals LLC | LACOSAMIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Patheon Italia S.p.A | LACOSAMIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sintetica US LLC | LACOSAMIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Trigen Laboratories, LLC | LACOSAMIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| UCB, Inc. | LACOSAMIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Westminster Pharmaceuticals, LLC | LACOSAMIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| XLCare Pharmaceuticals Inc. | LACOSAMIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Lifesciences Limited | LACOSAMIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Lacosamide — NDC 68083-0480-10," retrieved September 3, 2026, https://drugdashboards.com/drug/68083048010.
Free to cite with attribution — see how the data is put together.